Alkeon Capital Management
HCAT icon

Alkeon Capital Management’s Health Catalyst HCAT Stock Holding History

Alkeon Capital Management’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-502,500
Closed -$15.9M – 143
2019
Q3 		$15.9M Buy
+502,500
New +$19.8M 0.06% 113

Other funds holding HCAT

SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
NVPX
Norwest Venture Partners XI Palo Alto, California $32.1M AUM 15.68% 1-Year Est. Return
NVPX
Norwest Venture Partners XII Palo Alto, California $75.4M AUM 53.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alkeon Capital Management's HCAT Position: Q4 2019 in Review

Alkeon Capital Management sold out of Health Catalyst (HCAT) in Q4 2019, closing a stake of 502,500 shares — an estimated $15.9M sold.

Alkeon Capital Management first reported a position in HCAT in Q3 2019 and held it in 1 quarter. The position peaked at $15.9M in Q3 2019. 88 funds tracked by Wall St. Rank hold HCAT as of Q4 2019.

  • Alkeon Capital Management reported no remaining Health Catalyst position as of Q4 2019 after selling out during the quarter.
  • Alkeon Capital Management sold 502,500 Health Catalyst shares in Q4 2019, an estimated $15.9M.
  • Alkeon Capital Management first reported a position in Health Catalyst in Q3 2019 and held it in 1 quarter.
  • Alkeon Capital Management's Health Catalyst position peaked at $15.9M in Q3 2019.
  • 88 funds tracked by Wall St. Rank held Health Catalyst as of Q4 2019.

Based on Alkeon Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.